Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Viral Syndrome”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02531295
What this trial is testing

Immunologic Response to Kansui in Treated HIV+ Individuals: a Dose Escalation Study

Who this might be right for
HIVHuman Immunodeficiency Virus
University of California, San Francisco 5
Post-approval studies (Phase 4)Study completedNCT00795717
What this trial is testing

Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial

Who this might be right for
Cardiovascular DiseaseHIV Infection
Tufts University 41
Not applicableStudy completedNCT04677374
What this trial is testing

Uptake of Medical Male Circumcision Among Men With Sexually Transmitted Infections

Who this might be right for
HIV InfectionsSexually Transmitted Infections
University of North Carolina, Chapel Hill 2,242
Not applicableStudy completedNCT06091280
What this trial is testing

Home-Based Respiratory Muscle Strength Training Program for Individuals With Post-COVID-19 Persistent Dyspnea

Who this might be right for
Post-COVID-19 SyndromeDyspnea
University of South Florida 25
Not applicableStudy completedNCT04810559
What this trial is testing

Near Patient Study of the OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test in Oral Fluid and Fingerstick Whole Blood

Who this might be right for
HIV TestingHIV Infections
Unity Health Toronto 600
Testing effectiveness (Phase 2)Study completedNCT00002079
What this trial is testing

Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible)

Who this might be right for
HIV Infections
G D Searle
Not applicableStudy completedNCT01609426
What this trial is testing

Factors of Steroid Dependency in Idiopathic Nephrotic Syndrome

Who this might be right for
Idiopathic Nephrotic Syndrome
Assistance Publique - Hôpitaux de Paris 351
Post-approval studies (Phase 4)Study completedNCT00976040
What this trial is testing

Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal Meningitis

Who this might be right for
Cryptococcal MeningitisHIV Infections
Botswana-UPenn Partnership 28
Testing effectiveness (Phase 2)Study completedNCT00071890
What this trial is testing

Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 148
Large-scale testing (Phase 3)Not Yet RecruitingNCT05173324
What this trial is testing

Integration of HPV Vaccination and HPV-based Cervical Screening Into ARV Clinics: the H2VICTORY Trial

Who this might be right for
HPV Infection
International Agency for Research on Cancer 8,000
Early research (Phase 1)Study completedNCT00000680
What this trial is testing

A Phase I Study of Autologous, Activated CD8(+) Lymphocytes Expanded In Vitro and Infused With or Without Recombinant Interleukin-2 to Patients With AIDS or Severe ARC

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 6
Large-scale testing (Phase 3)Study completedNCT00450580
What this trial is testing

HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV-1 Infection
ViiV Healthcare 212
Large-scale testing (Phase 3)Ended earlyNCT00122525
What this trial is testing

Effect of Male Circumcision on HIV Incidence (ANRS 1265)

Who this might be right for
HIV InfectionsHerpes GenitalisVenereal Diseases
French National Agency for Research on AIDS and Viral Hepatitis 3,274
Testing effectiveness (Phase 2)WithdrawnNCT00614640
What this trial is testing

Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children, Adolescents, and Young Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT02422797
What this trial is testing

Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2)

Who this might be right for
HIV Infections
ViiV Healthcare 518
Not applicableUnknownNCT04482010
What this trial is testing

ANRS 12392 Sanu Gundo

Who this might be right for
HIV Infections
ANRS, Emerging Infectious Diseases 265
Not applicableStudy completedNCT00000915
What this trial is testing

An HIV Vaccine Preparedness Study

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 4,892
Testing effectiveness (Phase 2)Ended earlyNCT00095576
What this trial is testing

Investigation of V520 in an HIV Vaccine Proof-of-Concept Study (V520-023)

Who this might be right for
AIDSHIV Infections
Merck Sharp & Dohme LLC 3,000
Testing effectiveness (Phase 2)Study completedNCT01803074
What this trial is testing

Study to Evaluate a HIV Drug for the Treatment of HIV Infection

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 107
Testing effectiveness (Phase 2)Study completedNCT00213018
What this trial is testing

Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission

Who this might be right for
HIV InfectionsChlamydia TrachomatisNeisseria Gonorrhoeae+2 more
Population Council 400
Next Page